BeyondSpring Presents Lead Asset’s Mechanism Data for Prevention of Chemotherapy-Induced Neutropenia

NEXT STORY
Immunovaccine Announces Leading Independent Proxy Advisory Firms Recommend Voting for Share Consolidation Related to Potential Nasdaq Listing
PREV STORY
Global Point of Care (POC) Infectious Disease Diagnostic Testing Market Report 2018: Focus on Influenza, STD, HIV, Hepatitis, Malaria, C. difficile, E. coli, H. pylori & Home Test/OTC
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agenus to Report Third Quarter Earnings

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules.

FIT Biotech Oy                                                                                                           Company release 3.1.2019 at 15:30 EET FIT Biotech has received a ...

author_avatar
NASDAQ Market News

Veru Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-acting GnRH Antagonist Decapeptide Injection Formulation, for the Treatment of Hormone Sensitive Advanced Prostate Cancer

author_avatar
NASDAQ Market News